A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
Phase 2 Terminated
50 enrolled 18 charts
AcceleRET-Lung
Phase 3 Terminated
223 enrolled 18 charts
Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer
Phase 2 Terminated
14 enrolled 16 charts
Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer
Phase 1/2 Terminated
25 enrolled 11 charts
Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases
Phase 2 Terminated
3 enrolled 12 charts
Pembro+Chemo in Brain Mets
Phase 2 Terminated
3 enrolled 7 charts
CARMEN-LC05
Phase 2 Terminated
57 enrolled 26 charts
A Clinical Study of Bemcentinib With Standard of Care Chemoimmunotherapy in Untreated Advanced/Metastatic Non-small Cell Lung Cancer Patients With a Mutation in the STK11 Gene
Phase 1/2 Terminated
26 enrolled 13 charts
Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer
Phase 2 Terminated
265 enrolled 8 charts
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
1 enrolled 4 charts
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
Phase 2 Terminated
4 enrolled 9 charts
CONTERNO
Phase 3 Terminated
25 enrolled 10 charts
BIBF 1120 in Combination With Pemetrexed in Advanced Non Small Cell Lung Cancer (NSCLC)
Phase 1 Terminated
19 enrolled 16 charts
Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma
Phase 3 Terminated
16 enrolled 18 charts
Phalcis
Phase 2 Terminated
57 enrolled 18 charts
Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma
Phase 1/2 Terminated
9 enrolled 9 charts
Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer
Phase 3 Terminated
8 enrolled 7 charts
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
153 enrolled 13 charts
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
Phase 1/2 Terminated
67 enrolled 24 charts
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
Phase 2 Terminated
3 enrolled 8 charts
Genetic Predictors of Benefit to Pembrolizumab
Phase 2 Terminated
19 enrolled 12 charts
ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy
Phase 2 Terminated
1 enrolled 10 charts
PROPEL
Phase 1/2 Terminated
162 enrolled 21 charts
Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer
Phase 2 Terminated
30 enrolled 28 charts
Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer
Phase 2 Terminated
17 enrolled 8 charts
Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor
Phase 2 Terminated
3 enrolled 11 charts
Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
Phase 2 Terminated
5 enrolled 6 charts
Pemetrexed Disodium in Treating Patients With Previously Treated Metastatic Urothelial Cancer
Phase 2 Terminated
7 enrolled 5 charts
Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Terminated
39 enrolled 9 charts
A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma
Phase 1/2 Terminated
60 enrolled 24 charts
Trimodal Lung-Sparing Treatment of Pleural Mesothelioma
Phase 2 Terminated
9 enrolled 4 charts
2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer
Phase 2 Terminated
13 enrolled 13 charts
ARTEMIS
Phase 2 Terminated
124 enrolled 10 charts
S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib
Phase 2 Terminated
1 enrolled
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Phase 2 Terminated
66 enrolled 17 charts
Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
Phase 1/2 Terminated
42 enrolled 16 charts
TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy
Phase 3 Terminated
149 enrolled 17 charts
An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations
Phase 2 Terminated
59 enrolled 9 charts
Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
Phase 3 Terminated
2 enrolled 6 charts
Nintedanib (BIBF 1120) in Mesothelioma
Phase 2/3 Terminated
545 enrolled 15 charts
GSK1120212 Rollover Study
Phase 2 Terminated
159 enrolled 9 charts
Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLC
Phase 2 Terminated
23 enrolled 11 charts
Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer
Phase 1/2 Terminated
27 enrolled 18 charts
Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Phase 1 Terminated
4 enrolled 7 charts
Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
Phase 2 Terminated
17 enrolled 10 charts
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
Phase 2 Terminated
76 enrolled 13 charts
Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung Cancer
Phase 2 Terminated
1 enrolled 5 charts
Abraxane and Alimta in Advanced Solid Tumors
Phase 1/2 Terminated
49 enrolled 10 charts
NRR
Phase 2 Terminated
10 enrolled 14 charts
Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer
Phase 2 Terminated
1 enrolled 3 charts